Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
TGTX TG Therapeutics
- 29.340
- +0.130+0.45%
Close Feb 26 16:00 ET
4.57BMarket Cap-293.40P/E (TTM)
29.955High29.000Low1.30MVolume29.280Open29.210Pre Close38.28MTurnover0.90%Turnover Ratio326.00P/E (Static)155.67MShares36.84052wk High23.78P/B4.25BFloat Cap12.93052wk Low--Dividend TTM144.91MShs Float149414.006Historical High--Div YieldTTM3.27%Amplitude0.956Historical Low29.449Avg Price1Lot Size
TG Therapeutics News
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Maintains Target Price $10
Bank of America Securities Sticks to Its Sell Rating for TG Therapeutics (TGTX)
TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $50
TG Therapeutics Analyst Ratings
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $55
Strong Financial Outlook and Strategic Growth Opportunities Bolster Buy Rating for TG Therapeutics
B.Riley Financial Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $38
B.Riley Financial Reaffirms Their Buy Rating on TG Therapeutics (TGTX)
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Maintains Target Price $10
BofA Securities Adjusts Price Target on TG Therapeutics to $10 From $9, Maintains Underperform Rating
Jefferies Sticks to Their Buy Rating for TG Therapeutics (TGTX)
TG Therapeutics Analyst Ratings
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $43
J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $43
A Quick Look at Today's Ratings for TG Therapeutics(TGTX.US), With a Forecast Between $38 to $55
B. Riley Remains a Buyer of TG Therapeutics on Weakness Following Q3 Results
TG Therapeutics: Promising Growth Trajectory and Blockbuster Potential Justify Buy Rating
TD Cowen Initiates TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $50
TG Therapeutics Initiated at Buy by TD Cowen
TG Therapeutics Price Target Announced at $50.00/Share by TD Cowen